Literature DB >> 7984244

The X-ray structure of a growth hormone-prolactin receptor complex.

W Somers1, M Ultsch, A M De Vos, A A Kossiakoff.   

Abstract

The human pituitary hormones, growth hormone (hGH) and prolactin (hPRL), regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation. These activities are initiated by hormone-receptor binding. The hGH and hPRL receptors (hGHR and hPRLR, respectively) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily. This classification is based on sequence similarity in their extracellular domains, notably a highly conserved pentapeptide, the so-called 'WSXWS box', the function of which is controversial. All ligands in class 1 activate their respective receptors by clustering mechanisms. In the case of hGH, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. hPRL does not bind to the hGH receptor, but hGH binds to both the hGHR and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap. We present here the crystal structure of the 1:1 complex of hGH bound to the extracellular domain of the hPRLR. Comparisons with the hGH-hGHR complex reveal how hGH can bind to the two distinctly different receptor binding surfaces.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7984244     DOI: 10.1038/372478a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  79 in total

1.  The signal transducer gp130: solution structure of the carboxy-terminal domain of the cytokine receptor homology region.

Authors:  T Kernebeck; S Pflanz; G Müller-Newen; G Kurapkat; R M Scheek; K Dijkstra; P C Heinrich; A Wollmer; S Grzesiek; J Grötzinger
Journal:  Protein Sci       Date:  1999-01       Impact factor: 6.725

Review 2.  Recombinant analogues of prolactin, growth hormone, and placental lactogen: correlations between physical structure, binding characteristics, and activity.

Authors:  A Gertler
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-01       Impact factor: 2.673

Review 3.  Membrane catalysis of peptide-receptor binding.

Authors:  David N Langelaan; Jan K Rainey
Journal:  Biochem Cell Biol       Date:  2010-04       Impact factor: 3.626

4.  Human growth hormone fragment (hGH44-91) produces insulin resistance and hyperinsulinemia but is less potent than 22 kDa hGH in the rat.

Authors:  M Hettiarachchi; A Watkinson; K C Leung; Y N Sinha; K K Ho; E W Kraegen
Journal:  Endocrine       Date:  1997-02       Impact factor: 3.633

5.  Zinc binding to human lactogenic hormones and the human prolactin receptor.

Authors:  Jeffrey L Voorhees; Geeta Vittal Rao; Timothy J Gordon; Charles L Brooks
Journal:  FEBS Lett       Date:  2011-04-15       Impact factor: 4.124

6.  Determination of the energetics governing the regulatory step in growth hormone-induced receptor homodimerization.

Authors:  Bryan Bernat; Gabor Pal; Miao Sun; Anthony A Kossiakoff
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

7.  Obligate ordered binding of human lactogenic cytokines.

Authors:  Jeffery L Voorhees; Charles L Brooks
Journal:  J Biol Chem       Date:  2010-04-28       Impact factor: 5.157

8.  In silico investigation of pH-dependence of prolactin and human growth hormone binding to human prolactin receptor.

Authors:  Lin Wang; Shawn Witham; Zhe Zhang; Lin Li; Michael E Hodsdon; Emil Alexov
Journal:  Commun Comput Phys       Date:  2013-01       Impact factor: 3.246

Review 9.  Structural basis for recognition of MHC and MHC-like ligands by natural killer cell receptors.

Authors:  Lu Deng; Roy A Mariuzza
Journal:  Semin Immunol       Date:  2006-06       Impact factor: 11.130

10.  Structure and function of a new class of human prolactin antagonists.

Authors:  Laura DePalatis; Colleen M Almgren; Jypji Patmastan; Mark Troyer; Todd Woodrich; Charles L Brooks
Journal:  Protein Expr Purif       Date:  2009-02-21       Impact factor: 1.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.